Stoke Therapeutics Inc buy Guggenheim
Start price
07.02.26
/
50%
€26.60
Target price
07.02.27
€50.81
Performance (%)
4.51%
Price
30.03.26
€27.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 4.51%. This prediction currently runs until 07.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -3.472% | -3.472% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by Guggenheim for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for STOK provided by MarketBeat